Back to Journals » Drug Design, Development and Therapy » Volume 17

Original Research

UBE2T Promotes Temozolomide Resistance of Glioblastoma Through Regulating the Wnt/β-Catenin Signaling Pathway

       
Total article views   HTML views PDF downloads Totals
2,698 Dovepress* 2,454+ 74 2,528
PubMed Central* 244 120 364
Totals 2,698 194 2,892
*Since 5 May 2023

View citations on PubMed Central and Google Scholar